Click here for more information about Algenuity
Click here for more information about Liqofluxphenometrics515R1
Visit cricatalyst.com!Evodos Separation Technology Check out more of The Buzz spacer

Dr. Craig Behnke joins Lumen Bioscience as SVP

July 16, 2018
AlgaeIndustryMagazine.com

Dr. Craig Behnke has joined Lumen Bioscience as Senior Vice President, Production and Development.

Lumen Bioscience, a Seattle company developing novel biologics on its proprietary spirulina expression platform, has announced that Dr. Craig Behnke has joined its executive team as Senior Vice President, Production and Development.

Dr. Behnke will assume leadership of Lumen’s existing production and development teams. He joins as Lumen launches its first product, RioBlue™, a high-purity protein extract used as a blue colorant by the food and cosmetics industries. Dr. Behnke previously served as Vice President of Research and Development at Sapphire Energy in San Diego, a pioneer in the industrial-scale cultivation of photosynthetic microbes.

“We are pleased to welcome Dr. Behnke to Lumen’s senior leadership team,” said Brian Finrow, Lumen’s CEO and co-founder. “Craig’s experience makes him the perfect leader to scale commercial production beyond our current facility in Seattle. His scientific background and history of scaling up biological systems at Sapphire will be invaluable as we continue to expand our capacity.”

Used first as a nutritional supplement for its naturally high protein, vitamin and antioxidant content, US spirulina extract sales soared after 2014 when the FDA approved it for use as a natural food colorant. Today it remains the only approved natural blue food pigment in the US, and is used mainly as a natural alternative to FD&C Blue #1, an artificial food colorant that is synthesized from petroleum.

“I am thrilled to be joining such a talented group of scientists, engineers, and quality professionals,” Dr. Behnke said. “This team has built a robust, integrated, cGMP-compliant production system to produce the highest possible quality product. They’ve laid a great foundation as we look to scale production to meet global demand over the next 24-36 months. Over the course of my career I have had the good fortune to participate in some remarkable achievements in bio-process yield improvement, and I’m excited to help unlock the enormous commercial potential of this fascinating new platform.” Dr. Behnke holds a Ph.D. in Biochemistry from the University of Washington and an M.S. in Biochemistry from Kansas State.

In addition to its core colorants business, Lumen has also won research funding to use its new platform to develop ultra-low-cost biologic drugs and vaccines, all of which rely upon the same integrated, FDA cGMP production platform. In May, the National Institutes of Health awarded Lumen a grant to continue developing its oral malaria vaccine, and last month Lumen announced additional research funding from the United States Department of Agriculture and the Bill & Melinda Gates Foundation for other vaccine and antibody research programs.

More Buzz…

Copyright ©2010-2019 AlgaeIndustryMagazine.com. All rights reserved. Permission required to reprint this article in its entirety. Must include copyright statement and live hyperlinks. Contact editorial@algaeindustrymagazine.com. A.I.M. accepts unsolicited manuscripts for consideration, and takes no responsibility for the validity of claims made in submitted editorial.

twittertopbarlinks_eventstopbarlinks_requesttopbarlinks_archives

From The A.I.M. Archives

— Refresh Page for More Choices
“The Israeli food-tech industry has been growing in leaps and bounds in recent years and is taking a leading role worldwide with a broad range of innovative companies and...
At the Technical University of Denmark (DTU), Science Nordic.com reports, researchers are investigating bioluminescent algae, to determine whether bioluminescent organism...
Foodbev.com reports that French marine ingredients company Algaia will install a new specialty seaweed extract unit at its facility in Brittany, France, after securing €4...
Hayley Dunning writes from the Imperial College of London that a new discovery has changed our understanding of the basic mechanism of photosynthesis and should rewrite t...
Sophie Kevany writes in Decanter.com that a group of vineyards in France’s Bordeaux and Cognac regions are exploring whether algae can be used to prevent the fungal infec...
Alexander Richter writes in thinkgeoenergy.com that Israel-based Algaennovation last week signed a 15-year contract with Icelandic energy utility and operator ON Power fo...
Cécile Barbière writes for Euractive.fr (translated by Rob Kirby) that, in large greenhouses formerly home to the tomatoes and cucumbers of the market gardening Groupe Ol...
The Swiss Algae Consortium Association (SWALG) was founded in May 2018 as a non-profit organization that serves as a platform for algae-related activities in Switzerland ...
Nature.com reports that swimming algae have been enlisted to carry drugs to individual cells, raising the prospect that such “microswimmers” could deliver targeted therap...
London-based architectural and urban design firm ecoLogicStudio www.ecologicstudio.com, led by Claudia Pasquero and Marco Poletto, has unveiled Photo.Synth.Etica, a large...
Jessica D'Lima writes in AdvancedScienceNews.com that medicine is moving towards minimally invasive procedures, which have important patient-oriented benefits such as sho...
Susan Kraemer writes in solarpaces.org that to use solar thermal energy to convert farmed algae to fuel, the solar fuels research team at Australian National University (...